Literature DB >> 387600

Experimental cryptococcosis in normal and B-cell-deficient mice.

D P Monga, R Kumar, L N Mohapatra, A N Malaviya.   

Abstract

B-cell-deficient mice were prepared by administration of rabbit anti-mouse-mu antiserum to newborn animals within 12 h of birth onwards. Such immunodeficient animals, along with the normal controls, were infected intravenously with Cryptococcus neoformans. There was no difference in the mortality pattern, viable count of cryptococci in different organs, delayed-type hypersensitivity reaction, and antigen level in the sera of control and B-cell-deficient animals. Antibodies were absent in B-cell-deficient animals but were present in low titers in control animals. It is concluded that antibodies are not involved in protection of mice infected with C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387600      PMCID: PMC414564          DOI: 10.1128/iai.26.1.1-3.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Natural host resistance to infection with Cryptococcus neoformans. II. The influence of thiamine on experimental infection in mice.

Authors:  H H GADEBUSCH; P W GIKAS
Journal:  J Infect Dis       Date:  1963 Mar-Apr       Impact factor: 5.226

2.  Passive immunization against Cryptococcus neoformans.

Authors:  H H GADEBUSCH
Journal:  Proc Soc Exp Biol Med       Date:  1958-07

3.  Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis.

Authors:  R D Diamond
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

4.  Cell-mediated immunity in Cryptococcosis.

Authors:  J R Graybill; R H Alford
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

5.  Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans.

Authors:  R D Diamond; A C Allison
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

6.  Dissociated deficiency of cellular immunological function, cryptococcal meningitis and acute myeloid leukaemia.

Authors:  I J Forbes; R H Rischbieth
Journal:  Med J Aust       Date:  1972-03-25       Impact factor: 7.738

7.  Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.

Authors:  T R Kozel
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

8.  Cyclophosphamide effects on murine cryptococcosis.

Authors:  J R Graybill; L Mitchell
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

9.  Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans.

Authors:  J W Murphy; J A Gregory; H W Larsh
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

10.  Immunosuppression of mice injected with heterologous anti-immunoglobulin heavy chain antisera.

Authors:  D D Manning; J W Jutila
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307

View more
  26 in total

1.  Antibody immunity and natural resistance to cryptococcosis.

Authors:  N Trevijano-Contador; L Pirofski
Journal:  Curr Trop Med Rep       Date:  2019-04-04

Review 2.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 4.  The intracellular life of Cryptococcus neoformans.

Authors:  Carolina Coelho; Anamelia L Bocca; Arturo Casadevall
Journal:  Annu Rev Pathol       Date:  2013-09-16       Impact factor: 23.472

Review 5.  Pathogenesis of pelvic inflammatory disease.

Authors:  L Weström; P Wölner-Hanssen
Journal:  Genitourin Med       Date:  1993-02

6.  Influence of agglutinating antibody in experimental cryptococcal meningitis.

Authors:  J R Perfect; S D Lang; D T Durack
Journal:  Br J Exp Pathol       Date:  1981-12

7.  In vitro interactions of immune lymphocytes and Cryptococcus neoformans.

Authors:  P Y Fung; J W Murphy
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice.

Authors:  P K Maiti; A Kumar; R Kumar; L N Mohapatra
Journal:  Mycopathologia       Date:  1985-08       Impact factor: 2.574

10.  Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody.

Authors:  F Dromer; J Charreire; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.